Background Pharmacotherapy may represent a potential means to limit the expansion rate
of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different …

INTRODUCTION: Is it possible by pharmacological methods to attenuate the expansion rate
of abdominal aortic aneurysms? METHOD: An Internet-based systematic literature search …

Background: In the era of Abdominal Aortic Aneurysm (AAA) screening, pharmacotherapies
to attenuate AAA growth are sought. HMG Co-A reductase inhibitors (statins) have …

Background No effective treatment is currently available to prevent progression of small and
medium-sized abdominal aortic aneurysms (AAAs). Identification of drugs with sufficient …

BACKGROUND: Despite the absence of a relationship between cholesterol and abdominal
aortic aneurysm (AAA) expansion, there is evidence from a number of studies to suggest that …

OBJECTIVE: To determine whether statin therapy reduces the growth rate of small
abdominal aortic aneurysms (AAAs). DESIGN: A meta-analysis and a meta-regression of …

Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Background: To evaluate the effect of statins on the annual expansion rate (ER) of small
infrarenal abdominal aortic aneurysms (AAA). Patients and methods: All patients under …

Background Management of abdominal aortic aneurysms (AAAs) relies on surgical repair of
larger AAAs. Consequently medical interventions inhibiting AAA progression could greatly …

Background Abdominal aortic aneurysms (AAA) rupture can lead to patient death. Surgical
treatment is currently the optimal treatment for AAA with large diameter (≥ 50 mm). For AAA …